Based on the massive financial institution, Zealand Pharma is prone to attain gross sales of USD 9.9bn with its weight reduction candidate, petrelintide.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/j-p-morgan-sees-major-sales-potential-for-potential-zealand-pharma-partnership/